Time course of 75%–100% efficacy response of adjunctive brivaracetam

por Klein, Pavel, Laloyaux, Cédric, Elmoufti, Sami, Gasalla, Teresa, Martin, Melinda S.
Publicado 2020

Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials

por Ryvlin, Philippe, Dimova, Svetlana, Elmoufti, Sami, Floricel, Florin, Laloyaux, Cédric, Nondonfaz, Xavier, Biton, Victor
Publicado 2022

Towards realizing the vision of precision medicine: AI based prediction of clinical drug response

por de Jong, Johann, Cutcutache, Ioana, Page, Matthew, Elmoufti, Sami, Dilley, Cynthia, Fröhlich, Holger, Armstrong, Martin
Publicado 2021

Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational FαsT-CAN study

por Bessette, Louis, Haraoui, Boulos, Chow, Andrew, Fortin, Isabelle, Dixit, Sanjay, Khraishi, Majed, Haaland, Derek, Elmoufti, Sami, Staelens, Fabienne, Bogatyreva, Irina, Syrotuik, Jerry, Shaikh, Saeed
Publicado 2019